3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
38
Colorectal Neoplasms
18
Stomach Neoplasms
7
Biliary Tract Neoplasms
5
Rectal Neoplasms
3
Neoplasm Metastasis
3
Cholangiocarcinoma
3
Neoplasms
2
Metastatic Pancreatic Adenocarcinoma
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Wilms Tumor
1
Weight Loss
1
Triple Negative Breast Neoplasms
1
Small Bowel Adenocarcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Cancer Patients
1
Pseudomyxoma Peritonei
1
Peritoneal Neoplasms
1
Pancreatic cancer, adult
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Diseases
1
Pancreatic Cancer Non-resectable
1
Pancreatic Cancer Metastatic to Liver
1
Pancreatic Adenocarcinoma
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Interventions
irinotecan sucrosofate
1
Oxaliplatin
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoadjuvant Chemotherapy
×
irinotecan sucrosofate
×
Gastrointestinal
×
Clear all
NCT06172036
2023-12-15
CAPT-02
Zhejiang University
Phase 2
Not yet recruiting
180 enrolled